Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 7, 2016Virtual Press Office and PR Newswire: General Trade show news
RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, announced today it has been selected...
-
Sep 7, 2016Rodman & Renshaw 18th Annual Global Investment Conference - News
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced...
-
Sep 7, 2016Rodman & Renshaw 18th Annual Global Investment Conference - News
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to prevent or treat deadly inflammation and organ failure in...
-
Sep 7, 2016Virtual Press Office and PR Newswire: General Trade show news
Asterias Biotherapeutics, Inc. (NYSE MKT: AST), today announced that Edward Wirth, MD, PhD, Chief Medical Officer, will present interim efficacy data from the 10 million cell cohort in the...
-
Sep 7, 2016Rodman & Renshaw 17th Annual Global Investment Conference - News
Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual...